Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney
Yunyi Yan1, Nozomi Kondo1, Kentaro Oniki1
1Division of Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
Insights
Visit-to-visit variability in glycated hemoglobin (HbA1c) is linked to diabetic kidney disease (DKD) risk. The HbA1c area under the curve (HbA1c-AUC) shows promise as a prognostic indicator for microalbuminuria in type 2 diabetes.
Area of Science:
- Endocrinology
- Nephrology
- Metabolic Disorders
Background:
- Glycemic control is crucial for managing type 2 diabetes mellitus (T2DM).
- Visit-to-visit variability in glycated hemoglobin (HbA1c) has emerged as a potential risk factor for diabetic complications.
- Diabetic kidney disease (DKD) is a major microvascular complication of diabetes, characterized by albuminuria.
Purpose of the Study:
- To investigate the association between different measures of visit-to-visit HbA1c variability and the risk of developing or progressing diabetic kidney disease (DKD).
- To identify the most effective index for quantifying HbA1c variability in predicting DKD risk.
- To explore the role of oxidative stress in this relationship.
Main Methods:
- A clinic-based retrospective longitudinal study involving 699 Japanese patients with T2DM.
- Calculation of HbA1c variability using HbA1c standard deviation (HbA1c-SD), coefficient of variation (HbA1c-CV), change score (HbA1c-HVS), and area under the curve (HbA1c-AUC) over 3 years.
- Cox proportional hazards models, propensity score matching, and bootstrap analyses were employed to assess associations with DKD incidence and progression.
Main Results:
- Both HbA1c-SD and HbA1c-AUC were significantly associated with the incidence of microalbuminuria, independent of mean HbA1c levels.
- These findings were robust and replicated across different statistical analyses.
- Elevated HbA1c-SD and HbA1c-AUC were also correlated with higher levels of oxidized human serum albumin (HSA), a marker of oxidative stress.
Conclusions:
- Visit-to-visit HbA1c variability is an independent risk factor for microalbuminuria in T2DM patients, potentially mediated by oxidative stress.
- The HbA1c-AUC, a novel variability index, demonstrates potential as a prognostic indicator for predicting microalbuminuria risk.
Aims:
This study is aimed at clarifying the relationship between visit-to-visit variability of glycated hemoglobin (HbA1c) and the risk of diabetic kidney disease (DKD) and to identifying the most useful index of visit-to-visit variability of HbA1c.
Methods:
This clinic-based retrospective longitudinal study included 699 Japanese type 2 diabetes mellitus patients. Visit-to-visit variability of HbA1c was calculated as the internal standard deviation of HbA1c (HbA1c-SD), the coefficient of variation of HbA1c (HbA1c-CV), the HbA1c change score (HbA1c-HVS), and the area under the HbA1c curve (HbA1c-AUC) with 3-year serial HbA1c measurement data, and the associations between these indices and the development/progression of DKD were examined.
Results:
Cox proportional hazards models showed that the HbA1c-SD and HbA1c-AUC were associated with the incidence of microalbuminuria, independently of the HbA1c level. These results were verified and replicated in propensity score (PS) matching and bootstrap analyses. Moreover, the HbA1c-SD and HbA1c-AUC were also associated with oxidized human serum albumin (HSA), an oxidative stress marker.
Conclusions:
Visit-to-visit variability of HbA1c was an independent risk factor of microalbuminuria in association with oxidative stress among type 2 diabetes mellitus patients. HbA1c-AUC, a novel index of HbA1c variability, may be a potent prognostic indicator in predicting the risk of microalbuminuria.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Diabetes: Symptoms, Diagnosis, and Complications
Chronic Kidney Disease I: Introduction
Regression Toward the Mean


